Mark Rothera, Chief Commercial Officer at PTC THERAPEUTICS, INC. (PTCT), sold 8,000 shares at $35.72 ($290K) on 2014-09-15, disclosed to the SEC on 2014-09-16.
Scheduled sale ($290k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.72 | 3,160 | $113K | 38.9% |
| 2 | $36.41 | 1,840 | $67K | 23.1% |
| 3 | $36.68 | 3,000 | $110K | 38.0% |
| Total | $36.24 avg | 8,000 | $290K | 100% |
| Filing → |
| PTCT | SELL | 2015-03-18 | $820K | — | Filing → |
| PTCT | SELL | 2015-03-13 | $23K | — | Filing → |
| PTCT | SELL | 2015-02-25 | $2.4M | — | Filing → |